Intellimedix, a big data molecular profiling company, has utilized the most modern advancements in science and technology to develop algorithms that identify new treatments for previously 'untreatable' diseases. The Atlanta-based company employs world-class experts and leverages its notable partnerships with Pfizer, Beijing Genomics Institute (BGI), Epilepsy Foundation, MIT, Georgia Tech and Emory University to power precision medicine and compress the time needed to treat diseases by uniting molecular profiling with drug repurposing and discovery.
